Drug Database
Back to search

France· FR:68954908

TEZSPIRE 210 mg, solution injectable en seringue préremplie

A tezepelumab product containing tézépelumab, registered in France by ASTRAZENECA AB, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC R03DX11

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedTEZSPIRE 210 mg, solution injectable …ATCR03DX11REGISTER NO.FR:68954908PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tézépelumabAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tezepelumab is registered in 16 of 19 countries.

Countries holding a registration under ATC R03DX11 (tezepelumab), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose
Search tezepelumab products by name

Tezepelumab · ATC R03DX11

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tezepelumab costs, country by country.

Normalised to the WHO defined daily dose (7.5 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Tezepelumab · price per daily dose (7.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$48.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
TÉZÉPELUMAB
Manufacturer
ASTRAZENECA AB
Country
France (FR)
ATC code
R03DX11
ATC class
Tezepelumab
Defined daily dose
7.5 mg, P
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930261590
    1 seringue préremplie en verre de 1,91 mL
    EUR 1.01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tezepelumab in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tezepelumab products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Tezspire
  • Liechtenstein · Tezspire
  • Norway · Tezspire

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/78d2786e-188a-40c2-9e87-5c4cc97bc17e
GET /v1/drugs/78d2786e-188a-40c2-9e87-5c4cc97bc17e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68954908",
  "date_amm": "2022-09-19",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/22/1677",
  "substance": "TÉZÉPELUMAB",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}
API referenceMCP serverPlans

See everything about tezepelumab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console